Meeting
2021 ASCO Annual Meeting
Clinical outcomes analysis of TP53-mutated advanced and metastatic biliary tract cancers.
Authors
Sunyoung S. Lee
The University of Texas MD Anderson Cancer Center, Houston, TX
Sunyoung S. Lee , Hop Sanderson Tran Cao , Ching-Wei David Tzeng , Zeyad Metwalli , Eugene Jon Koay , Ethan B. Ludmir , Yun Shin Chun , Stephen G. Chun , Milind M. Javle
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Hepatobiliary Cancer
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 4106)
DOI
10.1200/JCO.2021.39.15_suppl.4106
Abstract #
4106
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Characterizing outcomes of ERBB2-amplified biliary tract cancer.
First Author: Daniel Aaron Fox
Poster
2023 ASCO Annual Meeting
Genomic targetability and survival outcomes of biliary tract cancers (BTC): A retrospective cohort study of the Australian Molecular Screening and Therapeutics (MoST) program.
First Author: Subotheni Thavaneswaran
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Epidemiological biliary tract cancer characterization: A patient cohort from the Spanish RETUD registry.
First Author: Teresa Macarulla
Poster
2021 ASCO Annual Meeting
Multimodal profiling of biliary tract cancers to detect potentially actionable biomarkers and differences in immune signatures between subtypes.
First Author: Kabir Mody